Research

Life Sciences & Biotechnology

Title :

New therapeutics against SARS–CoV-2: Analysing small molecule chemical libraries by establishing targeted cell-based assays for inhibitors of viral entry and viral protease

Area of research :

COVID-19 Research, Life Sciences & Biotechnology

Focus area :

Therapeutics for SARS-Cov-2

Principal Investigator :

Dr E Sreekumar, Scientist, Rajiv Gandhi Centre for Biotechnology (RGCB), Kerala

Timeline Start Year :

2020

Contact info :

Details

Executive Summary :

The study aims to develop cell-based assays to identify inhibitors of SARS-CoV-2 entry and also inhibitors of viral protease. It also plans to screen derivatives of Arbidol as virus entry inhibitors.

Organizations involved